Manipulating MicroRNAs to regulate macrophage polarization in gliomas

Journal of the National Cancer Institute

Volumn 106, Issue 8, 2014, Pages

  Anand, Sudarshan ^a   Coussens, Lisa M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 17C; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR BETA; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; MICRORNA; MICRORNA 142 3P; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ACTIN FILAMENT; CELL POLARITY; CELL SURVIVAL; DOWN REGULATION; EDITORIAL; GENE EXPRESSION; GENE FUNCTION; GLIOBLASTOMA; HEMANGIOBLAST; HUMAN; MEGAKARYOPOIESIS; MONOCYTE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN TUMOR; DRUG EFFECT; IMMUNOLOGY; MACROPHAGE; NOTE;

ANIMALS; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MACROPHAGES; MICRORNAS;

EID: 84930740116     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju230     Document Type: Editorial

References (22)

1. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012;33(3):119-126.
2. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39-51.
3. DeNardo DG, Brennan DJ, Rexhepaj E, et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011;1(1):54-67.
4. Mitchem JB, Brennan DJ, Knolhoff BL, et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res. 2013;73(3):1128-1141.
5. Mok S, Koya RC, Tsui C, et al. Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy. Cancer Res. 2014;74(1):153-161.
6. Pyonteck SM, Akkari L, Schuhmacher AJ, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19(10):1264-1272.
7. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597-610.
8. Xu Z, Zhao L, Zhu LY, et al. MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxiainducible factor 2alpha. PLoS One. 2013;8(10):e77890.
9. Squadrito ML, Pucci F, Magri L, et al. miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep. 2012;1(2):141-154.
10. Zhang M, Liu Q, Mi S, et al. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J Immunol. 2011;186(8):4716-4724.
11. Xu S, Wei J, Wang F, et al. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014; 106(8): dju162 doi:10.1093/jnci/dju162.
12. Wang X-S, Gong J-N, Yu J, et al. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood. 2012;119(21):4992-5004.
13. Sun Y, Sun J, Tomomi T, et al. PU.1-Dependent Transcriptional Regulation of miR-142 Contributes to Its Hematopoietic Cell-Specific Expression and Modulation of IL-6. J Immunol. 2013;190(8):4005-4013.
14. Lu X, Li X, He Q, et al. miR-142-3p regulates the formation and differentiation of hematopoietic stem cells in vertebrates. Cell Res. 2013;23(12):1356-1368.
15. Nimmo R, Ciau-Uitz A, Ruiz-Herguido C, et al. MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny. Dev Cell. 2013;26(3):237-249.
16. Chapnik E, Rivkin N, Mildner A, et al. miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis. eLIFE. 2014;10.7554/eLife.01964.
17. Lagrange B, Martin RZ, Droin N, et al. A role for miR-142-3p in colonystimulating factor 1-induced monocyte differentiation into macrophages. Biochim Biophys Acta. 2013;1833(8):1936-1946.
18. Sonda N, Simonato F, Peranzoni E, et al. miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis. Immunity. 2013;38(6):1236-1249.
19. Rouskin S, Zubradt M, Washietl S, et al. Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo. Nature. 2014;505(7485):701-705.
20. Ding Y, Tang Y, Kwok CK, et al. In vivo genome-wide profiling of RNA secondary structure reveals novel regulatory features. Nature. 2014;505(7485):696-700.
21. van Rooij E, Kauppinen S. Development of microRNA therapeutics is coming of age. EMBO Mol Med. 2014;10.15252/emmm.201100899.
22. Janssen HLA, Reesink HW, Lawitz EJ, et al. Treatment of HCV Infection by Targeting MicroRNA. N Engl J Med. 2013;368(18):1685-1694.